Epidemiology of de novo malignancies after solid-organ transplantation: Immunosuppression, infection and other risk factors

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 28, Issue 8, 2014, Pages 1251-1265

  Piselli, Pierluca ^a   Verdirosi, Diana ^a   Cimaglia, Claudia ^a   Busnach, Ghil ^b   Fratino, Lucia ^c   Ettorre, Giuseppe Maria ^d   De Paoli, Paolo ^c   Citterio, Franco ^e   Serraino, Diego ^c  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^d SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

Author keywords

cancer risk; iatrogenic immunosuppression; Kaposi's sarcoma; non Hodgkin lymphoma; oncogenic viruses; solid organ transplantation

Indexed keywords

AZATHIOPRINE; BLEOMYCIN; CISPLATIN; CYCLOSPORIN; DOXORUBICIN; INTERLEUKIN 10; INTERLEUKIN 6; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VINBLASTINE; VINCRISTINE;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BOWEN DISEASE; BRAIN HEMORRHAGE; CANCER RISK; CARCINOGENESIS; COLORECTAL CANCER; COLORECTAL CARCINOMA; CYTOKINE PRODUCTION; DNA DAMAGE; EPSTEIN BARR VIRUS INFECTION; FOLLOW UP; GENETIC TRAIT; GRAFT RECIPIENT; GRAFT SURVIVAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; INFECTION; INFECTION RISK; KAPOSI SARCOMA; KIDNEY CARCINOMA; KIDNEY TRANSPLANTATION; LIP CANCER; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALIGNANT TRANSFORMATION; MENSTRUATION DISORDER; MERKEL CELL TUMOR; MICROSATELLITE INSTABILITY; NEOPLASM; NON MELANOMA SKIN CANCER; ORGAN TRANSPLANTATION; PATHOGENESIS; PERSISTENT INFECTION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PREGNANCY OUTCOME; PRIMARY INFECTION; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK FACTOR; SECONDARY PREVENTION; SKIN CANCER; SUN EXPOSURE; SURGICAL TECHNIQUE; SURVIVAL RATE; TONSIL CANCER; TUMOR VIRUS; ADVERSE EFFECTS; CARCINOMA, RENAL CELL; FEMALE; INCIDENCE; ITALY; KIDNEY NEOPLASMS; LYMPHOPROLIFERATIVE DISORDERS; MALE; NEOPLASMS; PREGNANCY; SARCOMA, KAPOSI; SKIN NEOPLASMS; TIME;

CARCINOMA, RENAL CELL; FEMALE; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; ITALY; KIDNEY NEOPLASMS; LYMPHOPROLIFERATIVE DISORDERS; MALE; NEOPLASMS; ORGAN TRANSPLANTATION; PREGNANCY; RISK FACTORS; SARCOMA, KAPOSI; SKIN NEOPLASMS; TIME FACTORS;

EID: 84927137722     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2014.08.007     Document Type: Article

References (101)

1. Global Transplant data: Graphics and tables. Organ Donation and Transplantation Activities. Available at: http://www.transplant-observatory.org [accessed 01.07.14].
2. K.E. Lamb, S. Lodhi, and H.U. Meier-Kriesche Long-term renal allograft survival in the United States: a critical reappraisal Am J Transplant 11 2011 450 462
3. J.M. Campistol, V. Cuervas-Mons, and N. Manito New concepts and best practices for management of pre- and post-transplantation cancer Transplant Rev 26 2012 261 279
4. C.M. Vajdic, and M.T. Van Leeuwen Cancer incidence and risk factors after solid organ transplantation Int J Cancer 125 2009 1747 1754
5. T.F. Schulz Cancer and viral infections in immunocompromised individuals Int J Cancer 125 2009 1755 1763
6. V.T. Armenti, S. Constantinescu, and M.J. Moritz Pregnancy after transplantation Transplantation Review 22 2008 223 240
7. G.P. Dunn, A.T. Bruce, and H. Ikeda Cancer immunoediting: from immunosurveillance to tumour escape Nat Immunol 3 2002 991 998
8. M. Guba, C. Graeb, and K.W. Jauch Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation Transplantation 77 2004 1777 1782
9. M.T. van Leeuwen, A.C. Webster, and M.R. McCredie Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study BMJ 340 2010 c570
10. M. Rodríguez-Perálvarez, M. De la Mata, and A.K. Burroughs Liver transplantation: immunosuppression and oncology Curr Opin Organ Transplant 19 2014 253 260
11. A.D. Kirk, W.S. Cherikh, and M. Ring Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab Am J Transplant 7 2007 2619 2625
12. M. Maluccio, V. Sharma, and M. Lagman Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumour progression Transplantation 76 2003 597 602
13. F.S. Shihab, W.M. Bennett, and J. Isaac Nitric oxide modulates vascular endothelial growth factor and receptors in chronic cyclosporine nephrotoxicity Kidney Int 63 2003 522 533
14. J.E. Tanner, and J. Menezes Interleukin-6 and Epstein-Barr virus induction by cyclosporine A: potential role in lymphoproliferative disease Blood 84 1994 3956 3964
15. P.F. Swann, T.R. Waters, and D.C. Moulton Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine Science 273 1996 1109 1111
16. G. Végso, A. Sebestyén, and S. Paku Antiproliferative and apoptotic effects of mycophenolic acid in human B-cell non-Hodgkin lymphomas Leuk Res 31 2007 1003 1008
17. O.K. Eberhard, V. Kliem, and R. Brunkhorst Five cases of Kaposi's sarcoma in kidney graft recipients: possible influence of the immunosuppressive therapy Transplantation 67 1999 180 184
18. M.M. Hussein, J.M. Mooij, and H.M. Roujouleh Regression of post-transplant Kaposi sarcoma after discontinuing cyclosporin and giving mycophenolate mofetil instead Nephrol Dial Transplant 15 2000 1103 1104
19. H.M. Kauffman, W.S. Cherikh, and Y. Cheng Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies Transplantation 80 2005 883 889
20. A.P. Monaco The role of mTOR inhibitors in the management of post-transplant malignancy Transplantation 87 2009 157 163
21. R.R. Nepomuceno, C.E. Balatoni, and Y. Natkunam Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas Cancer Res 63 2003 4472 4480
22. M. Guba, P. von Breitenbuch, and M. Steinbauer Rapamycin inhibits primary and metastatic tumour growth by antiangiogenesis: involvement of vascular endothelial growth factor Nat Med 8 2002 128 135
23. M. Majewski, M. Korecka, and J. Joergensen Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft- protecting doses Transplantation 75 2003 1710 1717
24. H. Chen, J.M. Lee, and Y. Zong Linkage between STAT regulation and Epstein-Barr virus gene expression in tumours J Virol 75 2001 2929 2937
25. C. De Martel, J. Ferlay, and S. Franceschi Gobal burden of cancers attributable to infections in 2008: a review and synthetic analysis Lancet Oncol 13 2012 607 615
26. R.J. Biggar, A.K. Chaturvedi, and J.J. Goedert AIDS-related cancer and severity of immunosuppression in persons with AIDS J Natl Cancer Inst 99 2007 962 972
27. D. Serraino, P. Piselli, and P. Scognamiglio Viral infections and cancer: epidemiological aspects J Biol Regul Homeost Agents 15 2001 224 228
28. P. Piselli, G. Busnach, and L. Fratino De novo malignancies after organ transplantation: focus on viral infections Curr Mol Med 13 2013 1217 1227
29. V. Bouvard, R. Baan, and K. Straif A review of human carcinogens. part B: biological agents Lancet Oncol 10 2009 321 322
30. A. Carbone, E. Cesarman, and M. Spina HIV-associated lymphomas and gamma-herpesviruses Blood 113 2009 1213 1224
31. S. Euvrard, J. Kanitakis, and A. Claudy Skin cancers after organ transplantation New Engl J Med 348 2003 1681 1691
32. L.A. Denny, S. Franceschi, and S. De Sanjosé Human papillomavirus, human immunodeficiency virus and immunosuppression Vaccine 30 2012 F168 F174
33. B. Aldabagh, J.G. Angeles, and A.R. Cardones Cutaneous squamous cell carcinoma and human papillomavirus: is there an association? Dermatol Surg 39 2013 1 23
34. J. Wang, B. Aldabagh, and J. Yu Role of human papillomavirus in cutaneous squamous cell carcinoma: a meta-analysis J Am Acad Dermatol 70 2014 621 629
35. M.A. Nalesnik, and M.G. Ison Organ transplantation from deceased donors with cancer: is it safe? Open Access Surgery 4 2011 11 20
36. M.G. Ison, and M.A. Nalesnik An update on donor-derived disease transmission in organ transplantation Am J Transplant 11 2011 1123 1130
37. EBPG (European Expert Group on Renal Transplantation); European Renal Association (ERA-EDTA); European Society for Organ Transplantation (ESOT) European best practice guidelines for renal transplantation (part 1). Section II. Evaluation and selection of donors Nephrol Dial Transplant 15 2000 39 51
38. J.R. Chapman, and S.V. Lynch Donor-transmitted, donor-derived, and de novo cancer after liver transplant Exp Clin Transpl S1 2014 50 54
39. P.N. Martins, J. Pratschke, and A. Pascher Age and immune response in organ transplantation Transplantation 79 2005 127 132
40. S.A. Birkeland, H. Lokkegaard, and H.H. Storm Cancer risk in patients on dialysis and after renal transplantation Lancet 355 2000 1886 1887
41. E. Danpanich, and B.L. Kasiske Risk factors for cancer in renal transplant recipients Transplantation 68 1999 1859 1864
42. S. Saigal, S. Norris, and P. Muiesan Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation Liver Transpl 8 2002 482 487
43. S. Benlloch, M. Berenguer, and M. Prieto De novo internal neoplasms after liver transplantation: increased risk and aggressive behaviour in recent years? Am J Transplant 4 2004 596 604
44. C. Jiménez, E. Marqués, and C. Loinaz Upper aerodigestive tract and lung tumours after liver transplantation Transplant Proc 35 2003 1900 1901
45. S. Ben-Eliyahu, G.G. Page, and R. Yirmiya Acute alcohol intoxication suppresses natural killer cell activity and promotes tumour metastasis Nat Med 2 1996 457 460
46. S.K. Maitra, H. Gallo, and C. Rowland-Payne Second primary cancers in patients with squamous cell carcinoma of the skin Br J Cancer 92 2005 570 571
47. L. Kyllonen, K. Salmela, and E. Pukkala Cancer incidence in a kidney-transplanted population Tranpl Int 13 2000 S394 S398
48. B. Krynitz, G. Edgren, and B. Lindelöf Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008-a Swedish population-based study Int J Cancer 132 2013 1429 1438
49. H.M. Ramsay, A.A. Fryer, and S. Reece Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients Am J Kidney Dis 36 2000 167 176
50. M.C. Webb, F. Compton, and P.A. Andrews Skin tumours posttransplantation: a retrospective analysis of 28 years' experience at a single centre Transplant Proc 29 1997 828 830
51. J.C. Martinez, C.C. Otley, and T. Stasko Transplant-Skin Cancer Collaborative. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study Arch Dermatol 139 2003 301 306
52. J.R. Rubel, E.L. Milford, and R. Abdi Cutaneous neoplasms in renal transplant recipients Eur J Dermatol 12 2002 532 535
53. E.K. Geisller, and H.J. Schlitt The relation between immunosuppressive agents and malignancy Curr Opin Org Transp 9 2004 394 399
54. A.E. Grulich, M.T. van Leeuwen, and M.O. Falster Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis Lancet 370 2007 59 67
55. M.T. van Leeuwen, A.E. Grulich, and S.P. McDonald Immunosuppression and other risk factors for lip cancer after kidney transplantation Cancer Epidemiol Biomarkers Prev 18 2009 561 569
56. J.E. Ma, and J.D. Brewer Merkel cell carcinoma in immunosuppressed patients Cancer 6 2014 1328 1350
57. A.L. Taylor, R. Marcus, and J.A. Bradley Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation Crit Rev Oncol Hematol 56 2005 155 167
58. H. Tran, J. Nourse, and S. Hall Immunodeficiency-associated lymphomas Blood Rev 22 2008 261 281
59. Y. Dror, M. Greenberg, and G. Taylor Lymphoproliferative disorders after organ transplantation in children Transplantation 67 1999 990 998
60. H.H. Niller, D. Salamon, and K. Ilg EBV-associated neoplasms: alternative pathogenetic pathways Med Hypotheses 62 2004 387 391
61. S.Z. Gao, S.V. Chaparro, and M. Perlroth Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University J Heart Lung Transplant 22 2003 505 514
62. R.T. Bustami, A.O. Ojo, and R.A. Wolfe Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients Am J Transplant 4 2004 87 93
63. G. Opelz, and B. Dohler Lymphomas after solid organ transplantation: a collaborative transplant study report Am J Transplant 4 2004 222 230
64. F. Vincenti, and C.P. Larsen Alberu J at al. Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients Am J Transplant 12 2012 210 217
65. W.S. Cherikh, H.M. Kauffman, and M.A. McBride Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation Transplantation 76 2003 1289 1293
66. D.E. Tsai, C.L. Hardy, and J.E. Tomaszewski Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients Transplantation 71 2001 1076 1088
67. J.F. Buell, T.G. Gross, and E.S. Woodle Malignancy after transplantation Transplantation 80 2005 S254 S264
68. M. Orjuela, T.G. Gross, and Y.K. Cheung A pilot study of chemoimmunotherapy (cyclophosphamide, prednisone, and rituximab) in patients with post-transplant lymphoproliferative disorder following solid organ transplantation Clin Cancer Res 9 2003 S3945 S3952
69. I. Penn, and G. Porat Central nervous system lymphomas in organ allograft recipients Transplantation 59 1995 240 244
70. S. Choquet, S. Oertel, and V. LeBlond Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution Ann Hematol 86 2007 599 607
71. J. Pascual Post-transplant lymphoproliferative disorder-the potential of proliferation signal inhibitors Nephrol Dial Transplant 22 2007 i27 i35
72. C. Lebbé, C. Legendre, and C. Francès Kaposi sarcoma in transplantation Transplant Rev 22 2008 252 261
73. S. Euvrard, J. Kanitakis, and P. Cochat Skin cancers following paediatric organ transplantation Dermatol Surg 30 2004 616 621
74. P. Piselli, D. Serraino, and G.P. Segoloni Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009 Eur J Cancer 49 2013 336 344
75. G. Zavos, J. Bokos, and I. Papaconstantinou Clinicopathological aspects of 18 Kaposi's sarcoma among 1055 Greek renal transplant recipients Artif Organs 28 2004 595 599
76. L.A. García-Astudillo, and F. Leyva-Cobián Human herpesvirus-8 infection and Kaposi's sarcoma after liver and kidney transplantation in different geographical areas of Spain Transpl Immunol 17 2006 65 69
77. B. Einollahi, M. Lessan-Pezeshki, and M.H. Nourbala Kaposi's sarcoma following living donor kidney transplantation: review of 7,939 recipients Int Urol Nephrol 41 2009 679 685
78. W.Y. Qunibi, Y. Barri, and O. Alfurayh Kaposi's sarcoma in renal transplant recipients: a report on 26 cases from a single institution Transplant Proc 25 1993 1402 1405
79. I. Berber, G. Altaca, and C. Aydin Kaposi's sarcoma in renal transplant patients: predisposing factors and prognosis Transplant Proc 37 2005 967 968
80. A.E. El-Agroudy, M.A. El-Baz, and A.M. Ismail Clinical features and course of Kaposi's sarcoma in Egyptian kidney transplant recipients Am J Transplant 3 2003 1595 1599
81. N.H.T.M. Dukers, and G. Rezza Human herpesvirus 8 epidemiology: what we do and do not know AIDS 17 2003 1717 1730
82. C. Francès, A.G. Marcelin, and C. Legendre Skin and Organ Transplantation Group of the French Society of Dermatology. The impact of preexisting or acquired Kaposi sarcoma herpesvirus infection in kidney transplant recipients on morbidity and survival Am J Transplant 9 2009 2580 2586
83. M. Andreoni, D. Goletti, and P. Pezzotti Prevalence, incidence and correlates of HHV8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients J Infect 3 2001 195 199
84. D. Serraino, C. Angeletti, and M.P. Carrieri Kaposi's sarcoma in transplant and HIV-infected patients: an epidemiologic study in Italy and France Transplantation 80 2005 1699 1704
85. M. Luppi, P. Barozzi, and G. Guaraldi Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor Clin Infect Dis 37 2003 606 607
86. F.A. Shepherd, E. Maher, and C. Cardella Treatment of Kaposi's sarcoma after solid organ transplantation J Clin Oncol 15 1997 2371 2377
87. K. Antman, and Y. Chang Kaposi's sarcoma N Engl J Med 342 2000 1027 1038
88. C. Morath, W. Arns, and V. Schwenger Sirolimus in renal transplantation Nephrol Dial Transplant 22 2007 61 65
89. G.E. Koehl, H.J. Schlitt, and E.K. Geissler Rapamycin and tumour growth: mechanisms behind its anticancer activity Transplant Rev 19 2005 20 31
90. S. Montaner Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma Cell Cycle 6 2007 438 443
91. A. Andrés Cancer incidence after immunosuppressive treatment following kidney transplantation Crit Rev Oncol Hematol 56 2005 71 85
92. S.Y. Zafar, D.N. Howell, and J.P. Gockerman Malignancy after solid organ transplantation: an overview Oncologist 13 2008 769 778
93. A. Schwarz, S. Vatandaslar, and Merkel Renal cell carcinoma in transplant recipients with acquired cystic kidney disease Clin J Am Soc Nephrol 2 2007 750 756
94. J.D. Scandling Acquired cystic kidney disease and renal cell cancer after transplantation: time to rethink screening? Clin J Am Soc Nephrol 2 2007 621 622
95. I. Penn Primary kidney tumours before and after renal transplantation Transplantation 59 1995 480 485
96. H.T. Papaconstantinou, B. Sklow, and M.J. Hanaway Characteristics and survival patterns of solid organ transplant patients developing de novo colon and rectal cancer Dis Colon Rectum 47 2004 1898 1903
97. F.J. Moloney, H. Comber, and P. O'Lorcain A population-based study of skin cancer incidence and prevalence in renal transplant recipients Br J Dermatol 154 2006 498 504
98. A.C. Anyanwu, E.R. Townsend, and N.R. Banner Primary lung carcinoma after heart or lung transplantation: management and outcome J Thorac Cardiovasc Surg 124 2002 1190 1197
99. G. Ippoliti, M. Rinaldi, and C. Pellegrini Incidence of cancer after immunosuppressive treatment for heart transplantation Crit Rev Oncol Hematol 56 2005 101 113
100. R. Na, A.E. Grulich, and N.S. Meagher Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients Am J Transplant 13 2013 174 183
101. G. Opelz, and B. Dohler Treatment of kidney transplant recipients with ACEi/ARB and risk of respiratory tract cancer: a collaborative transplant study report Am J Transplant 11 2011 2483 2489